Clinical Trial Update: Caecal pH as a Biomarker for Irritable Bowel Syndrome [NA]

View source ↗

Summary

This update documents a clinical trial investigating caecal pH as a biomarker for irritable bowel syndrome, with the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: Wingate Institute of Neurogastroenterology | Conditions: Irritable Bowel Syndrome | NA | Status: UNKNOWN